Hippocampal P3-like auditory event-related potentials are disrupted in a rat model of cholinergic degeneration in alzheimer's disease: Reversal by donepezil treatment

Journal of Alzheimer's Disease

Volumn 42, Issue 4, 2014, Pages 1179-1189

  Laursen, Bettina ^a,b   Mørk, Arne ^a   Kristiansen, Uffe ^b   Bastlund, Jesper Frank ^a  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

192 IgG SAP; Alzheimer's disease; donepezil; P300 event related potential; rat

Indexed keywords

192 IGG SAPORIN; CHOLINE ACETYLTRANSFERASE; DONEPEZIL; IMMUNOTOXIN; SAPORIN; UNCLASSIFIED DRUG; 192 IGG-SAPORIN; INDAN DERIVATIVE; MONOCLONAL ANTIBODY; NEUROPROTECTIVE AGENT; PIPERIDINE DERIVATIVE; RIBOSOME INACTIVATING PROTEIN 1;

ALZHEIMER DISEASE; AMPLITUDE MODULATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY CORTEX; BRAIN DEGENERATION; BRAIN FUNCTION; CHOLINERGIC ACTIVITY; CHOLINERGIC DEGENERATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH ELECTRODE; DISEASE ASSOCIATION; ELECTRODE IMPLANTATION; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; EXPERIMENTAL BEHAVIORAL TEST; FOREBRAIN; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HUMAN; MALE; NONHUMAN; RAT; WORKING MEMORY; ANIMAL; CHOLINERGIC NERVE CELL; DISEASE MODEL; DRUG EFFECTS; ELECTRODE IMPLANT; HEARING; METABOLISM; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; AUDITORY PERCEPTION; CA1 REGION, HIPPOCAMPAL; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC NEURONS; DISEASE MODELS, ANIMAL; ELECTRODES, IMPLANTED; EVOKED POTENTIALS, AUDITORY; INDANS; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; PSYCHOMOTOR PERFORMANCE; RATS, SPRAGUE-DAWLEY; RIBOSOME INACTIVATING PROTEINS, TYPE 1;

EID: 84908011758     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131502     Document Type: Article

References (86)

1. Bennington JY, Polich J (1999) Comparison of P300 from passive and active tasks for auditory and visual stimuli. Int J Psychophysiol 34, 171-177.
2. Jodo E, Takeuchi S, Kayama Y (1995) P3b-like potential of rats recorded in an active discrimination task. Electroen-cephalogr Clin Neurophysiol 96, 555-560.
3. Picton TW (1992) The P300 wave of the human event-related potential. J Clin Neurophysiol 9, 456-579.
4. Donchin E (1981) Surprise.. Surprise? Psychophysiology 18, 493-513.
5. Johnson R (1988) Scalp-recorded P300 activity in patients following unilateral temporal lobectomy. Brain 111, 1517-1529.
6. Daffner KR, Rentz DM, Scinto LF, Faust R, Budson AE, Holcomb PJ (2001) Pathophysiology underlying diminished attention to novel events in patients with early AD. Neurology 56, 1377-1383.
7. Hattori M, Onoda K, Sakata S (2010) Identification of rat P3-like processes in the anterior cingulate cortex and hippocampus. Neurosci Lett 472, 43-46.
8. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW (1994) Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 271, 992-998.
9. Noldy N, Stelmack R, Campbell K (1990) Event-related potentials and recognition memory for pictures and words: The effects of intentional and incidental learning. Psy-chophysiology 27, 417-428.
10. Polich J, Kok A (1995) Cognitive and biological determinants of P300: An integrative review. Biol Psychol 41, 103-146.
11. Muscoso EG, Costanzo E, Daniele O, Maugeri D, Natale E, Caravaglios G (2006) Auditory event-related potentials in subcortical vascular cognitive impairment and Alzheimer's disease. J Neural Transm 113, 1779-1786.
12. Polich J, Ladish C, Bloom FE (1990) P300 assessmentofearly Alzheimer's disease. Electroencephalogr Clin Neurophysiol 77, 179-189.
13. Reeves RR, Struve FA, Patrick G, Booker JG, Nave DW (1999) The effects of donepezil on the P300 auditory and visual cognitive evoked potentials of patients with Alzheimer's disease. Am J Geriatr Psychiatry 7, 349-352.
14. O'Donnell BF, Friedman S, Swearer JM, Drachman D (1992) Active and passive P300 latency and psychometric performance: Influence of age and individual differences. Int J Psychophysiol 12, 185-187.
15. Polich J, Ehlers CL, Otis S, Mandell A, Bloom FE (1986) P300 latency reflects the degree of cognitive decline in dementing illness. Electroencephalogr Clin Neurophysiol 63, 138-144.
16. Squires NK, Galbraith G, Aine C (1979) Event-related potential assessment of sensory and cognitive deficits in the mentally retarded. In: Human Evoked Potentials: Applications and Problems, Lehmann D, Callaway E, eds. Plenum Press, New York, pp. 397-413.
17. Ally BA, Jones GE, Cole JA, Budson AE (2006) The P300 component in patients with Alzheimer's disease and their biological children. Biol Psychol 73, 180-187.
18. Boller F, El Massioui F, Devouche E, Traykov L, Pomati S, Starkstein SE (2002) Processing emotional information in Alzheimer's disease: Effects on memory performance and neurophysiological correlates. Dement Geriatr Cogn Disord 14, 104-112.
19. Ford J, Roth I, Tinklenberg R, Yesavage J, Pfefferbaum A (1997) Automatic and effortful processing in aging and dementia: Event-related brain potentials. Neurobiol Aging 18, 169-180.
20. Frodl T, Hampel H, Jucket G, Burger K, Padberg F, Engel RR, Möller HJ, Hegerl U (2002) Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment with Alzheimer's Disease. Psychophysiology 39, 175-181.
21. Yamaguchi S, Knight RT (1991) Anterior and posterior association cortex contributions to the somatosensory P300. J Neurosci 11, 2039-2054.
22. Frodl-Bauch T, Bottlender R, Hegerl U (1999) Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology 40, 86-94.
23. Callaway E (1983) The pharmacology of human information processing. Psychophysiology 20, 359-370.
24. Hollander E, Davidson M, Mohs RC, Horvath TB, Davis BM, Zimishlany Z, Davis KL (1987) RS 86 in the treatment of Alzheimer's disease: Cognitive and biological effects. Biol Psychiatry 22, 1067-1078.
25. Neshige R, Barrett G, Shibasaki H (1988) Auditory long latency event-related potentials in Alzheimer's disease and multi-infarct dementia. J Neurol Neurosurg Psychiatry 51, 1120-1125.
26. Thomas A, Iacono D, Bonanni L, D'Andreamatteo G, Onofrj M (2001) Donepezil, rivastigmine, and vitamin E in Alzheimer's disease: A combined P300 event-related potentials/neuropsychologic evaluation over 6 months. Clin Neuropharmacol 24, 31-42.
27. Werber EA, Gandelman-Marton R, Klein C, Rabey JM (2003) The clinical use of P300 event related potentials for evaluation of cholinesterase inhibitors treatment in demented patients. J Neural Transm 110, 659-669.
28. Lee MS, Lee SH, Moon EO, Moon YJ, Kim S, Kim SH, Jung IK (2013) Neuropsychological correlates of the P300 in patients with Alzheimer's disease. Prog Neuropsychophar-macol Biol Psychiatry 40, 62-69.
29. Siegel SJ, Connolly P, Liang Y, Lenox RH, Gur RE, Bilker WB, Kanes SJ, Turetsky BI (2003) Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology 28, 675-682.
30. Yamaguchi S, Globus H, Knight RT (1993) P3-like potential in rats. Electroencephalogr Clin Neurophysiol 88, 151-154.
31. Shinba T (1997) Event-related potentials of the rat during active and passive auditory oddball paradigm. Electroen-cephalogr Clin Neurophysiol 104, 447-452.
32. Wiley RG (1992) Neural lesioning with ribosome-inactivating proteins: Suicide transport and immunolesioning. Trends Neurosci 15, 285-290.
33. Heckers S, Ohtake T, Wiley RG, Lappi DA, Geula C, Mesulam M-M (1994) Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci 14, 1271-1289.
34. Drachman DA (1977) Memory and cognitive functionin man: Does the cholinergic system have a specific role? Neurology 27, 783-790.
35. Deutsch JA (1971) The cholinergic synapse and the site of memory. Science 174, 788-795.
36. Micheau J, Marighetto A (2011) Acetylcholine and memory: A long, complex and chaotic but still living relationship. Behav Brain Res 221, 424-429.
37. Chappell J, McMahan R, Chiba A, Gallagher M (1998) A re-examination of the role of basal forebrain cholinergic neurons in spatial working memory. Neuropharmacology 37, 481-487.
38. Frick KM, Kim JJ, Baxter MG (2004) Effects of complete immunotoxin lesionsofthe cholinergic basal forebrainonfear conditioning and spatial learning. Hippocampus 14, 244-254.
39. Klinkenberg I, Sambeth A, Blokland A (2011) Acetylcholine and attention. Behav Brain Res 221, 430-442.
40. Cutuli D, Foti F, Mandolesi L, De Bartolo P, Gelfo F, Federico F, Petrosini L (2009) Cognitive performances of cholinergically depleted rats following chronic donepezil administration. J Alzheimers Dis 17, 161-176.
41. McGaughy J, Dalley JW, Morrison CH, Everitt BJ, Robbins TW (2002) Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusion of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22, 1905-1913.
42. Sarter M, Bruno JP, Turchi J (1999) Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann NY Acad Sci 877, 368-382.
43. Walsh TJ, Herzog CD, Gandhi C, Stackman RW, Wiley RG (1996) Injection of IgG 192-saporin into the medial septum producescholinergic hypofunctionand dose-dependent working memory deficits. Brain Res 726, 69-79.
44. Hodges DB Jr, Lindner MD, Hogan JB, Jones KM, Markus EJ (2009) Scopolamine induced deficits in a battery of rat cog nitive tests: Comparisons of sensitivity and specificity. Behav Pharmacol 20, 237-251.
45. Shannon HE, Bemis KG, Hendrix JC, Ward JS (1990) Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats. J Pharmacol Exp Ther 255, 1071-1077.
46. Grauer E, Kapon J (1996) Differential effects of anti-cholinergic drugs on paired discrimination performance. Pharmacol Biochem Behav 53, 463-467.
47. Herron P, Li Z, Schweitzer JB (1998) Effects of cholinergic depletion on evoked activity in the cortex of young and aged rats. Int J Devl Neurosci 16, 633-643.
48. Gurley D, Leiser SC, Quirk MC, Doherty JJ, Christian EP (2010) Validation and pharmacological modulation of a P300 event related potential counterpart in behaving rodent. 2010 Neuroscience Meeting Planner (Online). Society for Neuroscience, San Diego, CA, Program No. 811.10/MMM3.
49. Mandolesi L, Bartolo PD, Foti F, Gelfo F, Federico F, Leggio MG, Petrosini L (2008) Environmental enrichment provides a cognitive reserve to be spent in the case of brain lesion. J Alzheimers Dis 15, 11-28.
50. Laursen B, Kristiansen U, Plath N, Mørk A, Bastlund JF (2013) Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice. Behav Brain Res 240, 146-152.
51. Paxinos G, Watson C (2002) The Rat Brain in Stereotaxic Coordinates, Academic Press, New York.
52. Jongsma MLA, Eichele T, Van Rijn CM, Coenen AML, Hugdahl K, Nordby H, Quiroga RQ (2006) Tracking pattern learning with single-trial event-related potentials. Clin Neurophysiol 117, 1957-1973.
53. Fonnum J (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24, 407-409.
54. Buccafusco JJ, Terry AV, Jr., Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE (2008) The scopolamine-reversal paradigm in rats and monkeys: The importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacol (Berl) 199, 481-494.
55. Polich J, Squire L (1993) P300 from amnesic patients with bilateral hippocampal lesions. Electroencephalogr Clin Neu-rophysiol 86, 408-417.
56. Maurer K, Ihl R, Dierks T (1988) Topography of P300 in psychiatry-II. Cognitive P300 fieldsin dementia. EEG-EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb 19, 26-29.
57. Shin J (2011) The interrelationship between movement and cognition: Theta rhythm and the P300 event-related potential. Hippocampus 21, 744-752.
58. Jeltsch H, Lazarus C, Cosquer B, Galani R, Cassel JC (2004) No facilitation of amphetamine-or cocaine-induced hyperac-tivity in adult rats after various 192 IgG-saporin lesions in the basal forebrain. Brain Res 1029, 259-271.
59. Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thal LJ (1995) 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience 65, 463-476.
60. Traissard N, Herbeaux K, Cosquer B, Jeltsch H, Ferry B, Galani R, Pernon A, Majchrzak M, Cassel J-C (2007) Combined damage to entorhinal cortex and cholinergic basal forebrain neurons, two early neurodegenerative features accompanying Alzheimer's disease: Effects on locomotor activity and memory functions in rats. Neuropsychopharma-cology 32, 851-871.
61. Waite JJ, Wardlow ML, Power AE (1999) Deficit in selected and divided attention associated with cholinergic basal forebrain immunotoxin lesion produced by 192-saporin; motoric/sensory deficit associated with purkinje cell immuno-toxic lesion produced by OX7-saporin. Neurobiol Learn Mem 71, 325-352.
62. Chen Z, Xu A-J, Li R, Wei E-Q (2002) Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147. Acta Pharmacol Sin 23, 355-360.
63. Sambeth A, Maes JH, van Luijtelaar G, Molenkamp IB, Jonqsma ML, van Rijn CM (2003) Auditory event-related potentials in humans and rats: Effects of task manipulation. Psychophysiology 40, 60-68.
64. Cutuli D, Foti F, Mandolesi L, De Bartolo P, Gelfo F, Fed-erico F, Petrosini L (2008) Cognitive performance of healthy young rats following chronic donepezil administration. Psy-chopharmacology 197, 661-673.
65. Golob EJ, Irimajiri R, Starr A (2007) Auditory cortical activity in amnestic mild cognitive impairment: Relationship to subtype and conversion to dementia. Brain 130, 740-752.
66. Michie PT, Fox AM, Ward PB, Catts SV, McConaghy N (1990) Event-related potential indices of selective attention and cortical lateralizationinschizophrenia. Psychophysiology 27, 209-227.
67. Sumich A, Castro A, Anilkumar APP, Zacharia E, Kumari V (2013) Neurophysiological correlates of excitement in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 46, 132-138.
68. Baxter MG, Bucci DJ, Gorman LK, Wiley RG, Gallagher M (2013) Selective immunotoxic lesions of basal forebrain cholinergic cells: Effects on learning and memory in rats. Behav Neurosci 127, 619-627.
69. Chappell J, McMahan R, Chiba A, Gallagher M (1998) A re-examination of the role of basal forebrain cholinergic neurons in spatial working memory. Neuropharmacology 37, 481-487.
70. Frick KM, Kim JJ, Baxter MG (2004) Effects of complete immunotoxin lesionsofthe cholinergic basal forebrainonfear conditioning and spatial learning. Hippocampus 14, 244-254.
71. Laursen B, Mørk A, Plath N, Kristiansen U, Bastlund JF (2014) Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration. Brain Res 1543, 253-262.
72. Brayda-Bruno L, Mons N, Yee BK, Micheau J, Abrous DN, Nogues X, Marighetto A (2013) Partial loss in septo-hippocampal cholinergic neurons alters memory-dependent measures of brain-connectivity without overt memory deficits. Neurobiol Dis 54, 372-381.
73. Rusiniak M, Lewandowska M, Wolak T, Pluta A, Milner R, Ganc M, Wlodarczyk A, Senderski A, Sliwa L, Skarz?ynski H (2013) A modified oddball paradigm for investigation of neural correlates of attention: A simultaneous ERP-fMRI study. MAGMA 26, 511-526.
74. Perry E, Walker M, Grace J, Perry R (1999) Acetylcholine in mind: A neurotransmitter correlate of consciousness? Trends Neurosci 22, 273-280.
75. Chudasama Y, Dalley JW, Nathwani F, Bouger P, Rob-bins TW (2004) Cholinergic modulation of visual attention and working memory: Dissociable effects of basal fore-brain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine. Learn Mem 11, 78-86.
76. Senkowski D, Herrmann CS (2002) Effects of task difficulty on evoked gamma activity and ERPs in a visual discrimination task. Clin Neurophys 113, 1742-1753.
77. Harrison JB, Buchwald JS, Kaga K, Woolf NJ, Butcher LL (1988) Cat P300 disappears after septal lesions. Electroen-cephalogr Clin Neurophysiol 69, 55-64.
78. O'Neill J, Halgren E, Marinkovic K, Siembieda D, Refai D, Fitten LJ, Perryman K, Fisher A (2000) Effects of muscarinic and adrenergic agonism on auditory P300 in the macaque. Physiol Behav 70, 163-170.
79. Polich J, Corey-Bloom J (2005) Alzheimer's disease and P300: Review and evaluation of task and modality. Curr Alzheimer Res 2, 515-525.
80. Barbeau A (1978) Emerging treatments: Replacement therapy with choline or lecithin in neurological diseases. Can J Neurol Sci 5, 157-160.
81. Mohs RC, Davies KL (1985) Interaction of choline and scopolamine in human memory. Life Sci 37, 193-197.
82. Grupe M, Grunnet M, Laursen B, Bastlund JF (2014) Neu-ropharmacological modulation of the P3-like event-related potential in a rat two-tone auditory discrimination task with modafinil and NS9283, a positive allosteric modulator of a4|32 nAChRs. Neuropharmacology 79, 444-455.
83. Patel SH, Azzam PN (2005) Characterization of N200 and P300: Selected studies of the event-related potential. Int J Med Sci 2, 147-154.
84. Hoffman JE (1990) Event-related potentials and automatic and controlled processes. In Event Related Brain Potentials, Rohrbaugh JW, Parasuraman R, Johnson R Jr, eds. Oxford University Press, New York, pp. 145-157.
85. Polich J (2004) Clinical application of the P300 event-related potential. Phys Med Rehab Clinics 15, 133-161.
86. Chapman RM, Nowlis GH, McCrary JW, Chapman JA, Sandoval TC, Guillily MD, Gardner MN, Reilly LA (2007) Brain event-related potentials: Diagnosing early-stage Alzheimer's disease. Neurobiol Aging 28, 194-201.